Invention Grant
- Patent Title: Polymorphic forms of icotinib and uses thereof
-
Application No.: US14896992Application Date: 2014-06-09
-
Publication No.: US09611272B2Publication Date: 2017-04-04
- Inventor: Shaojing Hu , Wei Long , Fei Wang , Yinxiang Wang , Lieming Ding
- Applicant: BETTA PHARMACEUTICALS CO., LTD
- Applicant Address: CN Hangzhou, Zhejiang
- Assignee: BETTA PHARMACEUTICALS CO., LTD.
- Current Assignee: BETTA PHARMACEUTICALS CO., LTD.
- Current Assignee Address: CN Hangzhou, Zhejiang
- Agency: Andrews Kurth Kenyon LLP
- Agent David Bradin
- Priority: WOPCT/CN2013/077095 20130609
- International Application: PCT/CN2014/079491 WO 20140609
- International Announcement: WO2014/198212 WO 20141218
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K45/06 ; C07D491/056 ; A61K9/20 ; A61K9/48
Abstract:
The present invention relates to the polymorphic forms of the compound of Formula I, preparation thereof and pharmaceutical compositions, and use of a polymorph above in the treatment of a disease, a disorder or a condition, or in the manufacturing of a medicament for the treatment of a disease, a disorder or a condition.
Public/Granted literature
- US20160108055A1 POLYMORPHIC FORMS OF ICOTINIB AND USES THEREOF Public/Granted day:2016-04-21
Information query
IPC分类:
